Eleonora Cella
Overview
Explore the profile of Eleonora Cella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
148
Citations
1426
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Webb J, Cella E, Sutcliffe C, Johnston C, Hassouneh S, Jubair M, et al.
Microb Genom
. 2025 Mar;
11(3).
PMID: 40085679
(SA) is an opportunistic pathogen and human commensal that is frequently present in the upper respiratory tract, gastrointestinal tract and skin. While SA can cause diseases ranging from minor skin...
2.
Giovanetti M, Cella E, Sampaio S, Elias M, Alcantara L, Slavov S
Int J Infect Dis
. 2025 Jan;
153:107793.
PMID: 39855336
No abstract available.
3.
Giovanetti M, Cella E, Sampaio S, Elias M, Slavov S
Vaccine
. 2025 Jan;
126755.
PMID: 39837735
No abstract available.
4.
Branda F, Cella E, Scarpa F, Slavov S, Bevivino A, Moretti R, et al.
Viruses
. 2025 Jan;
16(12.
PMID: 39772178
Wolbachia-based mosquito control strategies have gained significant attention as a sustainable approach to reduce the transmission of vector-borne diseases such as dengue, Zika, and chikungunya. These endosymbiotic bacteria can limit...
5.
Ali S, Giovanetti M, Johnston C, Urdaneta-Paez V, Azarian T, Cella E
Pathogens
. 2025 Jan;
13(12.
PMID: 39770354
The continual evolution of SARS-CoV-2 has significantly influenced the global response to the COVID-19 pandemic, with the emergence of highly transmissible and immune-evasive variants posing persistent challenges. The Omicron variant,...
6.
Cella E, Fonseca V, Branda F, Tosta S, Moreno K, Schuab G, et al.
Int J Infect Dis
. 2024 Oct;
149:107262.
PMID: 39389289
Background: Italy was significantly affected by the COVID-19 pandemic, experiencing multiple waves of infection following the sequential emergence of new variants. Understanding the transmission patterns and evolution of SARS-CoV-2 is...
7.
Schuab G, Tosta S, Moreno K, Fonseca V, Santos L, Slavov S, et al.
Lancet Reg Health Am
. 2024 Jul;
35:100835.
PMID: 39050558
[This corrects the article DOI: 10.1016/j.lana.2024.100786.].
8.
Schuab G, Tosta S, Moreno K, Fonseca V, Santos L, Slavov S, et al.
Lancet Reg Health Am
. 2024 Jun;
35:100786.
PMID: 38846808
Background: This study focuses on urban arboviruses, specifically dengue (DENV), chikungunya (CHIKV), and Zika (ZIKV), which pose a significant public health challenge in Rio de Janeiro state, Southeast Brazil. In...
9.
Cella E, Sutcliffe C, Grant L, Tso C, Weatherholtz R, Littlepage S, et al.
Microb Genom
. 2024 Mar;
10(3).
PMID: 38498591
Despite use of highly effective conjugate vaccines, invasive pneumococcal disease (IPD) remains a leading cause of morbidity and mortality and disproportionately affects Indigenous populations. Although included in the 13-valent pneumococcal...
10.
de Campos G, Cella E, Kashima S, Alcantara L, Sampaio S, Elias M, et al.
Viruses
. 2024 Feb;
16(2).
PMID: 38399947
Nipah virus (NiV), a biosafety level 4 agent, was first identified in human clinical cases during an outbreak in 1998 in Malaysia and Singapore. While flying foxes are the primary...